Fennec Pharmaceuticals (FENC) Net Cash Flow (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 357.77% |
| Sep 30, 2025 | 181.66% |
| Jun 30, 2025 | -0.28% |
| Mar 31, 2025 | 71.07% |
| Dec 31, 2024 | -400.59% |
| Sep 30, 2024 | 66.37% |
| Jun 30, 2024 | -121.44% |
| Mar 31, 2024 | 4,258.05% |
| Dec 31, 2023 | 134.00% |
| Sep 30, 2023 | 25.44% |
| Jun 30, 2023 | 36.26% |
| Mar 31, 2023 | 9.94% |
| Dec 31, 2022 | -140.29% |
| Sep 30, 2022 | 543.69% |
| Jun 30, 2022 | -17.71% |
| Mar 31, 2022 | 12.18% |
| Dec 31, 2021 | -9.36% |
| Sep 30, 2021 | 33.17% |
| Jun 30, 2021 | -23.18% |
| Mar 31, 2021 | -27.32% |
| Dec 31, 2020 | 49.27% |
| Sep 30, 2020 | -119.30% |
| Jun 30, 2020 | 868.95% |
| Mar 31, 2020 | -135.79% |
| Dec 31, 2019 | 28.86% |
| Sep 30, 2019 | 18.90% |
| Jun 30, 2019 | -8.08% |
| Mar 31, 2019 | -46.30% |
| Dec 31, 2018 | -56.18% |
| Sep 30, 2018 | -3.43% |
| Jun 30, 2018 | 29.98% |
| Mar 31, 2018 | -108.30% |
| Dec 31, 2017 | 3,513.97% |
| Sep 30, 2017 | -107.79% |
| Jun 30, 2017 | 1,134.22% |
| Mar 31, 2017 | -10.47% |
| Dec 31, 2016 | -12.32% |
| Sep 30, 2016 | -111.99% |
| Jun 30, 2016 | 1,242.57% |
| Mar 31, 2016 | 6.37% |
| Dec 31, 2015 | 13.11% |
| Sep 30, 2015 | -687.10% |
| Jun 30, 2015 | 84.14% |
| Mar 31, 2015 | -122.81% |
| Dec 31, 2014 | 506.16% |
| Sep 30, 2014 | -30.65% |
| Jun 30, 2014 | 0.62% |
| Mar 31, 2014 | -128.89% |
| Dec 31, 2013 | 339.87% |
| Sep 30, 2013 | 47.24% |
| Jun 30, 2013 | -118.43% |
| Mar 31, 2013 | 26.93% |
| Dec 31, 2012 | 23.28% |
| Sep 30, 2012 | 35.92% |
| Jun 30, 2012 | -96.02% |
| Mar 31, 2012 | 24.64% |
| Dec 31, 2011 | -20.60% |
| Sep 30, 2011 | -135.89% |
| Jun 30, 2011 | 269.08% |
| Mar 31, 2011 | -60.00% |
| Dec 31, 2010 | -19.09% |
| Sep 30, 2010 | -108.08% |